HOLX - Hologic, Inc.
After hours:
| Previous close | 78.51 |
| Open | 78.77 |
| Bid | 79.07 x 900 |
| Ask | 81.41 x 900 |
| Day's range | 78.69 - 79.51 |
| 52-week range | 59.78 - 87.88 |
| Volume | |
| Avg. volume | 1,329,275 |
| Market cap | 19.485B |
| Beta (5Y monthly) | 1.00 |
| PE ratio (TTM) | 26.08 |
| EPS (TTM) | 3.03 |
| Earnings date | 25 July 2023 - 31 July 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 92.12 |
ZacksVeeva Systems (VEEV) Offerings Adopted by Minaris Regenerative
Veeva Systems' (VEEV) Vault Quality Suite applications are expected to aid the CDMO to modernize its operations and streamline its quality processes globally.
ZacksHere's Why You Should Retain Globus Medical (GMED) Stock Now
Investors continue to be optimistic about Globus Medical (GMED) based on the strong performances across geographies and the pending NuVasive acquisition.
ZacksZacks Industry Outlook Highlights Hologic, Masimo and Integer
Hologic, Masimo and Integer have been highlighted in this Industry Outlook article.
ZacksMedtronic (MDT) Q4 Earnings Beat Estimates, Margins Down
Strong growth in the Cardiovascular, Medical Surgical, and Neuroscience portfolios, and in Diabetes markets drove Medtronic (MDT) Q4 revenues.
- Zacks
Here's Why You Should Retain Bruker (BRKR) Stock for Now
Investors continue to be optimistic about Bruker Corporation (BRKR) based on the strong performances of CALID and BioSpin Group and its raised 2023 outlook.
- Zacks
Masimo's (MASI) Platform Expansion to Boost Patient Monitoring
Masimo's (MASI) latest expansion to its HEOS platform will likely revolutionize health and wellness tracking by allowing connected care as consumers become tetherless and smartphone-less.
Zacks3 Medical Instruments Stocks to Buy Amid Industry Challenges
The Zacks Medical - Instruments industry is growing on rising demand for digital health. HOLX, MASI and ITGR are set to gain the most. Yet, ongoing inflation, in the form of rising freight and raw material costs, is disrupting the trend.
ZacksBoston Scientific (BSX) Gains From Acquisitions, New Launches
Boston Scientific (BSX) remains excited about 2023 performance and expects to continue to outpace its peers within the EMEA market.
ZacksAbbott (ABT) Unveils Late-Breaking Data on Leadless Pacemaker
Abbott (ABT) study analyzes primary safety and efficacy endpoints in the first 300 people enrolled across 55 centers in the United States, Canada and Europe.
ZacksAccuray (ARAY) Hits 52-Week High: What's Aiding the Stock?
Investors are optimistic about Accuray's (ARAY) solid product portfolio.
- Zacks
Veeva Systems' (VEEV) New Tie-Up to Improve Clinical Trials
Veeva Systems' (VEEV) latest collaboration is expected to advance the patient experience in clinical trials.
- Zacks
Here's Why You Should Retain Chemed (CHE) Stock for Now
Investors continue to be optimistic about Chemed (CHE) on the strong performance of the VITAS Healthcare and Roto-Rooter segments.
ZacksAvantor's (AVTR) New Tie-Up to Improve Lab Inventory Management
Avantor's (AVTR) latest partnership is expected to significantly optimize labs' inventory management and the overall workflow.
- Zacks
3 Reasons to Add Merit Medical (MMSI) Stock to Your Portfolio
Investors continue to be optimistic about Merit Medical (MMSI) owing to its strong product portfolio.
- Zacks
Here's Why You Should Retain Insulet (PODD) Stock for Now
Investors continue to be optimistic about Insulet (PODD) on the robust performance of Omnipod 5.
- Zacks
3 Reasons to Hold Inspire Medical (INSP) Stock in Your Portfolio
Investors continue to be optimistic about Inspire Medical (INSP) on the back of its product innovations.
ZacksBD's (BDX) Latest Product Launch to Boost Research Outcome
BD's (BDX) latest cell sorting technology is expected to speed up the process of cell sorting and allow researchers to answer complex biological questions.
ZacksHologic (HOLX) Gets FDA Nod for Multiplexed Respiratory Test
Hologic's (HOLX) Panther Fusion SARS-CoV-2/Flu A/B/RSV assay is done using the fully-automated, high-throughput Panther Fusion system.
ZacksWhat's in the Cards for Medtronic (MDT) in Q4 Earnings?
Medtronic (MDT) is likely to have prioritized its R&D investments, which might get reflected in the fiscal Q4 results.
- Zacks
Veeva Systems' (VEEV) New Launch to Improve Patient Outcomes
Veeva Systems' (VEEV) new offering is expected to facilitate effective engagement with customers and KOLs for improved patient journeys.
Business WireHologic Announces FDA Clearance of Panther Fusion SARS-CoV-2/Flu A/B/RSV Assay
MARLBOROUGH, Mass., May 19, 2023--Hologic Announces FDA Clearance of Panther Fusion SARS-CoV-2/Flu A/B/RSV Assay
ZacksHere's Why You Should Retain QIAGEN (QGEN) Stock for Now
QIAGEN (QGEN) is likely to benefit from high organic growth across its non-COVID-19 product group and portfolio advancements, reflecting a positive share price movement.
ZacksBD's (BDX) New FDA Approval to Improve MRSA Diagnostics
BD's (BDX) receipt of the latest FDA approval is likely to improve laboratory workflow.
ZacksHere's Why You Should Retain Myriad Genetics (MYGN) Stock Now
Myriad Genetics (MYGN) is likely to benefit from testing volumes across product segments and the latest partnerships, reflecting a positive share price movement.
ZacksNextGen (NXGN) Q4 Earnings Top Estimates, Revenues Surge Y/Y
NextGen's (NXGN) fourth-quarter fiscal 2023 results reflect strength in both its revenue sources.